FI954147L - Polypeptider - Google Patents

Polypeptider Download PDF

Info

Publication number: FI954147L
Authority: FI; Finland
Prior art keywords: polypeptides
Prior art date: 1994-09-06

Application number

FI954147A

Other languages

English (en)

Finnish (fi)

Other versions

FI117424B (sv

FI954147A0 (sv

Inventor

Rainer Albert

Christian Bruns

Peter Smith-Jones

Barbara Stolz

Gisbert Weckbecker

Original Assignee

Sandoz Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-06

Filing date

1995-09-04

Publication date

1996-03-07

1995-09-04 Application filed by Sandoz Ltd filed Critical Sandoz Ltd

1995-09-04 Publication of FI954147A0 publication Critical patent/FI954147A0/sv

1996-03-07 Publication of FI954147L publication Critical patent/FI954147L/sv

2006-10-13 Application granted granted Critical

2006-10-13 Publication of FI117424B publication Critical patent/FI117424B/sv

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Optics & Photonics (AREA)
Physics & Mathematics (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
Toxicology (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

FI954147A 1994-09-06 1995-09-04 Peptider FI117424B (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9417873A GB9417873D0 (en)	1994-09-06	1994-09-06	Organic compounds
GB9417873		1994-09-06

Publications (3)

Publication Number	Publication Date
FI954147A0 FI954147A0 (sv)	1995-09-04
FI954147L true FI954147L (sv)	1996-03-07
FI117424B FI117424B (sv)	2006-10-13

Family

ID=10760870

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI954147A FI117424B (sv)	1994-09-06	1995-09-04	Peptider

Country Status (31)

Country	Link
US (2)	US6183721B1 (sv)
EP (1)	EP0714911B1 (sv)
JP (1)	JP3054346B2 (sv)
KR (1)	KR100364111B1 (sv)
CN (1)	CN1185252C (sv)
AT (1)	ATE199561T1 (sv)
AU (1)	AU703057B2 (sv)
BR (1)	BR9503936A (sv)
CA (1)	CA2157530C (sv)
CO (1)	CO4410344A1 (sv)
CZ (1)	CZ287012B6 (sv)
DE (1)	DE69520256T2 (sv)
DK (1)	DK0714911T3 (sv)
ES (1)	ES2157309T3 (sv)
FI (1)	FI117424B (sv)
GB (1)	GB9417873D0 (sv)
GR (1)	GR3035997T3 (sv)
HU (1)	HU218284B (sv)
IL (1)	IL115154A (sv)
NO (1)	NO316569B1 (sv)
NZ (1)	NZ272919A (sv)
PE (1)	PE41496A1 (sv)
PL (1)	PL182434B1 (sv)
PT (1)	PT714911E (sv)
RU (1)	RU2156774C2 (sv)
SG (1)	SG50356A1 (sv)
SI (1)	SI0714911T1 (sv)
SK (1)	SK283774B6 (sv)
TR (1)	TR199501094A2 (sv)
TW (1)	TW387898B (sv)
ZA (1)	ZA957475B (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9417873D0 (en) *	1994-09-06	1994-10-26	Sandoz Ltd	Organic compounds
AT405906B (de) *	1997-03-14	1999-12-27	Irene Dr Virgolini	Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie
US6358491B1 (en)	1999-08-27	2002-03-19	Berlex Laboratories, Inc.	Somatostatin analogs
EP3406249A1 (en)	2001-02-19	2018-11-28	Novartis AG	Treatment of breast tumors with a rapamycin derivative in combination with an aromatase inhibitor
HUP0304083A2 (hu) *	2001-02-26	2004-03-29	Bristol-Myers Squibb Pharma Company	Radiofarmakon kompozíciók, előállításuk és eljárás radiofarmakonok pufferolására
ITMI20011708A1 (it) *	2001-08-03	2003-02-03	Bracco Imaging Spa	Coniugati di peptidi, loro derivati con complessi metallici e utilizzo per i'indagine diagnostica tramite imaging per risonanza magnetica(m
NZ538284A (en)	2002-07-18	2008-04-30	Helix Biopharma Corp	Use of urease and targeting molecule for inhibiting cancer cell growth
EP1610805A2 (en) *	2003-03-10	2006-01-04	Biogen Idec Inc.	Thiol-mediated drug attachment to targeting peptides
CN102532321B (zh)	2004-06-18	2018-10-12	Ambrx公司	新颖抗原结合多肽和其用途
WO2006056443A2 (en) *	2004-11-24	2006-06-01	Aplagen Gmbh	Method for solid-phase peptide synthesis and purification
EP2348052A3 (en)	2007-09-17	2011-10-26	The Regents of The University of California	Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
WO2012125582A1 (en)	2011-03-11	2012-09-20	Board Of Regents Of The University Of Nebraska	Biomarker for coronary artery disease
EP2922578B1 (en)	2012-11-21	2018-12-12	Serene, Llc	Tin-117m comprising somatostatin receptor binding compounds
CN103275189B (zh) *	2013-06-06	2014-08-06	深圳翰宇药业股份有限公司	一种用于肽树脂的裂解液及其在固相裂解合成生长抑素中的应用
SI4095130T1 (sl) *	2013-10-18	2024-05-31	Novartis Ag	Označeni zaviralci za prostato specifičnega membranskega antigena (PSMA), njihova uporaba kot kontrastna sredstva in farmacevtska sredstva za zdravljenje raka prostate
SI3383920T1 (sl)	2015-11-30	2024-06-28	The Regents Of The University Of California	Dostava tumorsko specifičnega koristnega tovora in imunska aktivacija z uporabo humanega protitelesa, ki cilja visoko specifičen površinski antigen tumorskih celic
WO2018044812A2 (en)	2016-08-29	2018-03-08	Fred Hutchinson Cancer Research Center	Chelating platform for delivery of radionuclides
WO2018089829A1 (en)	2016-11-10	2018-05-17	Fortis Therapeutics, Inc.	Cd46-specific effector cells and uses thereof
HRP20231458T1 (hr)	2017-01-12	2024-05-10	Radiomedix Inc.	Liječenje stanica raka koje prekomjerno eksprimiraju receptore za somatostatin primjenom derivata oktreotida keliranih sa radioizotopima
TW202017600A (zh) *	2018-06-21	2020-05-16	法商艾普森藥品公司	用於放射性醫藥之含有體抑素類似物之組成物
TW202015744A (zh)	2018-06-21	2020-05-01	法商艾普森藥品公司	用於放射性醫藥之含有體抑素類似物之組成物
TW202019489A (zh)	2018-07-25	2020-06-01	義大利商先進艾斯雷特應用（義大利）公司	穩定的、濃縮的放射性核種錯合物溶液
US10596276B2 (en)	2018-07-25	2020-03-24	Advanced Accelerator Applications (Italy) S.R.L.	Stable, concentrated radionuclide complex solutions
US10596278B2 (en)	2018-07-25	2020-03-24	Advanced Accelerator Applications (Italy) S.R.L.	Stable, concentrated radionuclide complex solutions
BR112023002346A2 (pt)	2020-08-07	2023-05-02	Fortis Therapeutics Inc	Imunoconjugados direcionados a cd46 e métodos de uso dos mesmos

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5006643A (en)	1987-06-24	1991-04-09	The Dow Chemical Company	Process for preparing isothiocyanato functionalized metal complexes
DE3728600A1 (de)	1987-08-27	1989-03-09	Hoechst Ag	Verfahren zur markierung von substanzen mit technetium oder rhenium
EP0416033B1 (en) *	1988-05-25	1996-03-06	THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce	Macrocyclic chelates and methods of use thereof
MY106120A (en) *	1988-12-05	1995-03-31	Novartis Ag	Peptide derivatives.
GB9111199D0 (en) *	1991-05-23	1991-07-17	Sandoz Ltd	Improvements in or relating to organic compounds
ATE136224T1 (de)	1989-09-29	1996-04-15	Neorx Corp	Reduktion der nichtzielspezifischen retention von immunokonjugaten und ihren metaboliten
WO1993018797A1 (en) *	1992-03-25	1993-09-30	Mallinckrodt Medical, Inc.	Method of intraoperatively detecting and locating tumoral tissues
NZ250653A (en) *	1993-01-12	1995-12-21	Sandoz Ltd	Somatostatin derivatives and pharmaceutical or diagnostic imaging compositions
US5650134A (en) *	1993-01-12	1997-07-22	Novartis Ag (Formerly Sandoz Ltd.)	Peptides
US5705143A (en) *	1994-01-12	1998-01-06	Amersham International Plc	Biological targeting agents
GB9417873D0 (en) *	1994-09-06	1994-10-26	Sandoz Ltd	Organic compounds

1994
- 1994-09-06 GB GB9417873A patent/GB9417873D0/en active Pending
1995
- 1995-09-04 IL IL11515495A patent/IL115154A/xx not_active IP Right Cessation
- 1995-09-04 DK DK95810545T patent/DK0714911T3/da active
- 1995-09-04 FI FI954147A patent/FI117424B/sv not_active IP Right Cessation
- 1995-09-04 RU RU95114740/04A patent/RU2156774C2/ru active
- 1995-09-04 NO NO953457A patent/NO316569B1/no not_active IP Right Cessation
- 1995-09-04 DE DE69520256T patent/DE69520256T2/de not_active Expired - Lifetime
- 1995-09-04 SI SI9530491T patent/SI0714911T1/xx unknown
- 1995-09-04 EP EP95810545A patent/EP0714911B1/en not_active Expired - Lifetime
- 1995-09-04 NZ NZ272919A patent/NZ272919A/en not_active IP Right Cessation
- 1995-09-04 PE PE1995277844A patent/PE41496A1/es not_active IP Right Cessation
- 1995-09-04 SG SG1995001282A patent/SG50356A1/en unknown
- 1995-09-04 SK SK1088-95A patent/SK283774B6/sk not_active IP Right Cessation
- 1995-09-04 PL PL95310274A patent/PL182434B1/pl unknown
- 1995-09-04 CZ CZ19952263A patent/CZ287012B6/cs not_active IP Right Cessation
- 1995-09-04 AU AU30414/95A patent/AU703057B2/en not_active Expired
- 1995-09-04 PT PT95810545T patent/PT714911E/pt unknown
- 1995-09-04 ES ES95810545T patent/ES2157309T3/es not_active Expired - Lifetime
- 1995-09-04 AT AT95810545T patent/ATE199561T1/de active
- 1995-09-04 HU HU9502577A patent/HU218284B/hu unknown
- 1995-09-05 KR KR1019950028905A patent/KR100364111B1/ko not_active Expired - Lifetime
- 1995-09-05 CN CNB951156101A patent/CN1185252C/zh not_active Expired - Lifetime
- 1995-09-05 JP JP7227906A patent/JP3054346B2/ja not_active Expired - Lifetime
- 1995-09-05 BR BR9503936-8A patent/BR9503936A/pt not_active IP Right Cessation
- 1995-09-05 CO CO95040393A patent/CO4410344A1/es unknown
- 1995-09-05 CA CA002157530A patent/CA2157530C/en not_active Expired - Lifetime
- 1995-09-06 TR TR95/01094A patent/TR199501094A2/xx unknown
- 1995-09-06 ZA ZA957475A patent/ZA957475B/xx unknown
- 1995-09-08 TW TW084109395A patent/TW387898B/zh not_active IP Right Cessation
1997
- 1997-04-23 US US08/842,125 patent/US6183721B1/en not_active Expired - Lifetime
2000
- 2000-07-05 US US09/609,844 patent/US6277356B1/en not_active Expired - Lifetime
2001
- 2001-06-06 GR GR20010400850T patent/GR3035997T3/el unknown

Also Published As

Publication number	Publication date
IL115154A (en)	2000-08-13
EP0714911B1 (en)	2001-03-07
CZ226395A3 (en)	1996-03-13
US6277356B1 (en)	2001-08-21
SK108895A3 (en)	1996-06-05
FI117424B (sv)	2006-10-13
BR9503936A (pt)	1996-09-24
JP3054346B2 (ja)	2000-06-19
DE69520256T2 (de)	2001-08-09
GB9417873D0 (en)	1994-10-26
DE69520256D1 (de)	2001-04-12
ES2157309T3 (es)	2001-08-16
EP0714911A3 (en)	1996-08-21
PT714911E (pt)	2001-08-30
NO953457D0 (no)	1995-09-04
TR199501094A2 (tr)	1996-06-21
CO4410344A1 (es)	1997-01-09
HUT72895A (en)	1996-06-28
PE41496A1 (es)	1996-10-14
FI954147A0 (sv)	1995-09-04
GR3035997T3 (en)	2001-09-28
SI0714911T1 (en)	2001-08-31
TW387898B (en)	2000-04-21
KR100364111B1 (ko)	2003-02-05
DK0714911T3 (da)	2001-07-09
SK283774B6 (sk)	2004-01-08
NO953457L (no)	1996-03-07
CN1127259A (zh)	1996-07-24
IL115154A0 (en)	1995-12-31
ATE199561T1 (de)	2001-03-15
SG50356A1 (en)	2000-11-21
HU9502577D0 (en)	1995-11-28
AU703057B2 (en)	1999-03-11
US6183721B1 (en)	2001-02-06
CZ287012B6 (en)	2000-08-16
PL310274A1 (en)	1996-03-18
RU2156774C2 (ru)	2000-09-27
KR960010683A (ko)	1996-04-20
NZ272919A (en)	1996-12-20
PL182434B1 (pl)	2002-01-31
ZA957475B (en)	1997-03-06
EP0714911A2 (en)	1996-06-05
CA2157530A1 (en)	1996-03-07
JPH0881498A (ja)	1996-03-26
CA2157530C (en)	2007-04-03
HU218284B (en)	2000-07-28
AU3041495A (en)	1996-03-21
CN1185252C (zh)	2005-01-19
NO316569B1 (no)	2004-02-23

Publication	Publication Date	Title
FI972312L (sv)	1997-12-30	Nya polypeptider vilka härstammar frånhedgehog
DE69533099D1 (de)	2004-07-08	Zytoanalysator
FI961350L (sv)	1996-03-25	Hapten-märkta peptider
FI954147L (sv)	1996-03-07	Polypeptider
FI970168L (sv)	1997-01-15	Peptider
DE69533805D1 (de)	2004-12-30	Kolbenultraschallumwandler
DE59506964D1 (de)	1999-11-04	Polyglycerinpolyricinoleate
FI964363L (sv)	1996-12-23	Peptider
FI961504A0 (sv)	1996-04-03	Pappersmaskintorkviror
BR7400683U (pt)	1995-11-14	Odontoportátil
SE9601085D0 (sv)	1996-03-21	Novel polypeptides
SE9502007D0 (sv)	1995-06-01	Novel polypeptides
FI1681U1 (fi)	1994-12-30	Bindtrosor
BR9402584A (pt)	1996-02-27	Chavecheque
BR9400078A (pt)	1995-09-26	Emergensos
BR9404091A (pt)	1996-10-01	Muchileiro
BR9403990A (pt)	1995-06-06	Quandriciclo ciclo-car
BR9403759A (pt)	1996-10-15	Mastercalc
BR9403758A (pt)	1996-10-15	Multiplic
BR9403310A (pt)	1996-05-21	Regulex
BR9403309A (pt)	1996-05-26	Choppometro
BR9403098A (pt)	1996-09-03	Turnimetro
BR9405358A (pt)	1996-12-03	Moto-eletro-continuo
BR9401966A (pt)	1995-12-05	Intervalômetro-foto ARJ-07
FI945003A0 (fi)	1994-10-25	Torkningskaenk

Legal Events

Date	Code	Title	Description
1997-08-07	GB	Transfer or assigment of application	Owner name: NOVARTIS AG
2006-10-13	FG	Patent granted	Ref document number: 117424 Country of ref document: FI
2015-10-23	MA	Patent expired

Date

Code

Title

Description

1997-08-07

Transfer or assigment of application

Owner name: NOVARTIS AG

2006-10-13

Patent granted

Ref document number: 117424

Country of ref document: FI

2015-10-23

Patent expired